galactosamine has been researched along with Macrophage Activation Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhahri, D; Eiamboonsert, S; Hattori, K; Heissig, B; Munakata, S; Nakauchi, H; Okada, Y; Onoda, H; Ota, Y; Salama, Y; Shimazu, H; Tashiro, Y; Tsuda, Y | 1 |
1 other study(ies) available for galactosamine and Macrophage Activation Syndrome
| Article | Year |
|---|---|
Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndrome.
Topics: Animals; Disease Models, Animal; Fibrinolysin; Galactosamine; Humans; Macrophage Activation Syndrome; Mice; Mice, Knockout; RAW 264.7 Cells; Toll-Like Receptor 9 | 2017 |